News | October 21, 2022
Cadila Pharma's Esiloc wins "Best Launch of the Year"
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism resulting in toxic sulfite levels causing neurologic sequelae
This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
Cumulatively, almost 75% of the health centres in the country have been electrified with a cumulative solar capacity of 3.5 MW
The company increases its efficiency and is able to face the growing demand for its services.
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Subscribe To Our Newsletter & Stay Updated
